Literature DB >> 2421018

Alpha 2 adrenergic receptors in hyperplastic human prostate: identification and characterization using [3H] rauwolscine.

E Shapiro, H Lepor.   

Abstract

[3H]Rauwolscine ([3H]Ra), a selective ligand for the alpha 2 adrenergic receptor, was used to identify and characterize alpha 2 adrenergic receptors in prostate glands of men with benign prostatic hyperplasia. Specific binding of [3H]Ra to prostatic tissue homogenates was rapid and readily reversible by addition of excess unlabelled phentolamine. Scatchard analysis of saturation experiments demonstrates a single, saturable class of high affinity binding sites (Bmax = 0.31 +/- 0.04 fmol./microgram. DNA, Kd = 0.9 +/- 0.11 nM.). The relative potency of alpha adrenergic drugs (clonidine, alpha-methylnorepinephrine and prazosin) in competing for [3H]Ra binding sites was consistent with the order predicted for an alpha 2 subtype. The role of alpha 2 adrenergic receptors in normal prostatic function and in men with bladder outlet obstruction secondary to BPH requires further investigation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2421018     DOI: 10.1016/s0022-5347(17)45971-4

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

1.  The medical therapy of prostatic symptoms study: what will we learn?

Authors:  Kevin M Slawin
Journal:  Rev Urol       Date:  2003

2.  The medical therapy of prostatic symptoms study: what will we learn?

Authors:  Kevin M Slawin
Journal:  Rev Urol       Date:  2003

3.  Pathophysiology of benign prostatic hyperplasia: insights from medical therapy for the disease.

Authors:  Herbert Lepor
Journal:  Rev Urol       Date:  2009

4.  The evolution of alpha-blockers for the treatment of benign prostatic hyperplasia.

Authors:  Herbert Lepor
Journal:  Rev Urol       Date:  2006

Review 5.  Benign prostatic hyperplasia. Practical treatment guidelines.

Authors:  T Tammela
Journal:  Drugs Aging       Date:  1997-05       Impact factor: 3.923

6.  Is there a peripheral site of action contributing to the voiding effects of α₂-adrenoceptor agonists and antagonists?

Authors:  Erik Aro; Sanna Bastman; Karl-Erik Andersson; Tomi Streng
Journal:  World J Urol       Date:  2014-06-07       Impact factor: 4.226

7.  Alpha blockers for the treatment of benign prostatic hyperplasia.

Authors:  Herbert Lepor
Journal:  Rev Urol       Date:  2007

Review 8.  Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate.

Authors:  Martin C Michel; Wim Vrydag
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

Review 9.  Lower urinary tract symptoms in men.

Authors:  John M Hollingsworth; Timothy J Wilt
Journal:  BMJ       Date:  2014-08-14

10.  A prospective pilotstudy comparing the anesthetic effects of an alpha-2 agonist during holmium laser resection of the prostate and transurethral resection for prostate surgery for benign prostatic hyperplasia patients using selective alpha-1 blockers.

Authors:  Do-Won Lee; Jiseok Baik; Giyoung Yun; Soeun Jeon; Hyae-Jin Kim; Eun-Soo Kim; Hyeon Jeong Lee; Jae-Young Kwon
Journal:  BMC Anesthesiol       Date:  2018-09-27       Impact factor: 2.217

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.